Source: Farmaindustria.es Representatives of the Spanish Agency of Medicines and Health Products, research teams, pharmaceutical industry and patient organizations agree on the opportunity and need to […]
Source: farmaindustria.es The commitment of the pharmaceutical industry to the research and development of treatments for rare diseases is indisputable and, as the data show, growing. […]
Source: Farmaindustria.es Various facts and arguments support the condition of Spain as an attractive country for the development of biopharmaceutical research projects: the quality of its […]
Source: Farmaindustria.es Investigate and develop new medicines more and more precise and effective, facilitate the access of patients to these innovative drugs in an environment of […]
Source: actasanitaria.com The Health Institute Carlos III (ISCIII) has announced that, through European programs, has “about five million euros” to participate in the latest calls open […]
Source: actasanitaria.com The Spanish Agency for Medicines and Healthcare Products (AEMPS) has published the correction of errors of version 10 of the document of instructions for […]
Source: Immedicohospitalario.es Bellicum Pharma has reported the preliminary results of its phase I / II dose escalation study in 12 patients with metastatic pancreatic cancer treated […]
Source: Immedicohospitalario.es The studies published by the CNIC scientists during the year 2017 consolidate this center as an institution of Spanish and international research excellence, highlighting […]
Source: immedicohospitalario.es Researchers from the universities of Vienna and Lancaster have developed a method aimed at improving precision medicine already during the clinical development phase of […]
Source: redaccionmedica.com A common medication for diabetes, combined with a drug against high blood pressure, is able to inhibit the growth of tumorese induce the death […]
Source: immedicohospitalario.es Systemic lupus erythematosus (SLE) is an autoimmune disease with multifaceted and extremely variable clinical manifestations, characterized by relapses and outbreaks followed by periods of […]
Source: Laverdad.es Spain has become the second country in the world where more clinical trials are carried out, only surpassed by the United States, the hegemonic […]